Raymond Benza, MD
Advanced Heart Failure and Transplant Cardiology · Norfolk, VANPI 1366497430
Payments from drug & device makers
Across 247 payments — averaging $3093.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$488K
- Abbott$130K
- Actelion Pharmaceuticals, Ltd$34K
- Janssen Research & Development, LLC$31K
- Merck$25K
- Insmed, Inc.$18K
- plus $39K from 16 others
Across 13 payments — averaging $2248.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- United Therapeutics Corporation$24K
- Insmed, Inc.$5K
What the payments were for
- Consulting fees$110,65079%
- Speaking & faculty fees$8,9406%
- Travel & lodging$11,6688%
- Food & beverage$7,9616%
- Education$100%
- Other$1,3271%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 77 | $487,824 |
| Abbott | 62 | $130,388 |
| Actelion Pharmaceuticals, Ltd | 11 | $33,545 |
| Janssen Research & Development, LLC | 19 | $31,293 |
| Merck | 20 | $24,771 |
| Insmed, Inc. | 12 | $17,626 |
| Bayer | 8 | $11,288 |
| Actelion Pharmaceuticals US, Inc. | 17 | $10,078 |
| Sumitomo Pharma America, Inc. | 1 | $6,000 |
| Acceleron Pharma, Inc. | 1 | $5,340 |
| Astrazeneca UK Limited | 1 | $3,480 |
| Eko Health, Inc. | 3 | $1,327 |
| Cipla USA Inc. | 1 | $550 |
| Liquidia Technologies, Inc. | 1 | $140 |
| Abiomed | 3 | $103 |
| Sandoz | 3 | $87 |
| Boston Scientific | 1 | $83 |
| Analog Devices Inc. | 2 | $46 |
| Novo Nordisk | 1 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Endotronix, Inc. | 1 | $24 |
| Amgen | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$15,495
- AMPLATZER Occluders$10,100
- OPSUMIT$8,231
- Adempas$7,375
- CardioMEMS HF System$5,892
- HeartMate$4,050
- HeartMate 3 Left Ventricular Dev$2,000
- HeartMate Touch$1,500
- HeartMate 3 Left Ventricular Assist Device$1,500
- CARDIOMEMS$1,250
- TYVASO$813
- UPTRAVI$500
- ORENITRAM$347
- REMODULIN$336
- WINREVAIR$282
- YUTREPIA$140
How this compares
$764,081 in reported general payments places this provider in the 95th percentile of 43 advanced heart failure and transplant cardiology providers in Virginia.
See all advanced heart failure and transplant cardiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Norfolk
- Amin YehyaNorfolk$643K
- Manjula AnanthramNorfolk$532K
- Zackary TushakNorfolk$92K
- Robert BernsteinNorfolk$27K
- John HerreChesapeake$672K
- Palak ShahFalls Church$662K
- Keyur ShahRichmond,$573K
- Mirnela BykuCharlottesville$414K
- Jamie KennedyFalls Church$354K
- Wayne OldChesapeake$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.